Dianthus Therapeutics

DNTH

Börsenwert 5 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 TRV GP IV Boston, Massachusetts	121 Mio. $	–	–	–
2	2 Gilder Gagnon Howe & Co New York	62,2 Mio. $	-505.083 $	-2.703	-1 %
3	3 Eventide Asset Management Boston, Massachusetts	51,5 Mio. $	+5,12 Mio. $	+27.403	+15 %
4	4 Alphabet Inc Mountain View, California	50,6 Mio. $	–	–	–
5	5 Casdin Capital New York	47 Mio. $	+583.938 $	+3.125	+2 %
6	6 BlackRock New York	25,1 Mio. $	+15.136 $	+81	+0,1 %
7	7 Vanguard Group Malvern, Pennsylvania	13,4 Mio. $	-29.150 $	-156	-0,3 %
8	8 Alkeon Capital Management New York	9,1 Mio. $	+1,17 Mio. $	+6.250	+20 %
9	OM 9 Opaleye Management Boston, Massachusetts	6,73 Mio. $	+758.465 $	+4.059	+17 %
10	10 State Street Boston, Massachusetts	5,51 Mio. $	+366.432 $	+1.961	+9 %
11	11 Harvard Management Company Boston, Massachusetts	5,04 Mio. $	–	–	–
12	12 Geode Capital Management Boston, Massachusetts	3,92 Mio. $	+176.770 $	+946	+6 %
13	13 Bessemer Group Woodbridge, New Jersey	3,6 Mio. $	–	–	–
14	14 Principal Financial Group Des Moines, Iowa	3,5 Mio. $	-2.990 $	-16	-0,1 %
15	15 Northern Trust Chicago, Illinois	3,5 Mio. $	-48.957 $	-262	-2 %
16	16 Platinum Investment Management Sydney Australia 2000, Australia	3,15 Mio. $	-635.511 $	-3.401	-21 %
17	17 Fidelity Investments Boston, Massachusetts	2,09 Mio. $	–	–	–
18	18 Marshall Wace North America New York	1,94 Mio. $	+1,5 Mio. $	+8.006	Neu
19	19 Millennium Management New York	1,89 Mio. $	+1,46 Mio. $	+7.810	Neu
20	20 Ensign Peak Advisors Salt Lake City, Utah	1,58 Mio. $	+1,22 Mio. $	+6.511	Neu
21	21 Citadel Advisors Miami, Florida	1,33 Mio. $	-1,08 Mio. $	-5.791	-51 %
22	22 Bank of New York Mellon New York	953.000 $	+34.756 $	+186	+5 %
23	23 Nuveen Charlotte, North Carolina	782.000 $	-19.433 $	-104	-3 %
24	24 JP Morgan Chase New York	743.000 $	+499.103 $	+2.671	+678 %
25	25 Charles Schwab San Francisco, California	735.000 $	–	–	–

Dianthus Therapeutics DNTH Börsenwert 5 Mrd. $

Dianthus Therapeutics

DNTH

Börsenwert 5 Mrd. $